TIGIT negatively regulates inflammation by altering macrophage phenotype

Immunobiology

Volumn 221, Issue 1, 2016, Pages 48-55

  Chen, Xi ^a   Lu, Pu Han ^a   Liu, Lei ^a   Fang, Ze Min ^a   Duan, Wu ^a   Liu, Zhe Long ^a   Wang, Cong Yi ^a   Zhou, Ping ^a   Yu, Xue Feng ^a   He, Wen Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

LPS; Macrophage; Polarization; PVR; TIGIT

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; POLIOVIRUS RECEPTOR; PROTEIN TIGIT; TRANSCRIPTION FACTOR C MAF; UNCLASSIFIED DRUG; VIRUS RECEPTOR; IL10 PROTEIN, MOUSE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN RECEPTOR; MAF PROTEIN, MOUSE; T CELL IG AND ITIM DOMAIN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE MIGRATION INHIBITION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SEPTIC SHOCK; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; MACROPHAGE ACTIVATION; MORTALITY; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

ANIMALS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INFLAMMATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; NIH 3T3 CELLS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MAF; RECEPTORS, IMMUNOLOGIC; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84946499176     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.08.003     Document Type: Article

References (36)

1. Murray P.J., Allen J.E., Biswas S.K., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41:14-20.
2. Benoit M., Desnues B., Mege J.L. Macrophage polarization in bacterial infections. J. Immunol. 2008, 181:3733-3739.
3. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
4. Kambara K., Ohashi W., Tomita K., et al. In vivo depletion of CD206+ M2 macrophages exaggerates lung injury in endotoxemic mice. Am. J. Pathol. 2015, 185:162-171.
5. Arranz A., Doxaki C., Vergadi E., et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9517-9522.
6. Kamran N., Takai Y., Miyoshi J., et al. Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells. PLoS One 2013, 8:e54406.
7. Yu X., Harden K., Gonzalez L.C., et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 2009, 10:48-57.
8. Chan C.J., Martinet L., Gilfillan S., et al. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 2014, 15:431-438.
9. Xu Z., Jin B. A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell. Mol. Immunol. 2010, 7:11-19.
10. Joller N., Hafler J.P., Brynedal B., et al. Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. J. Immunol. 2011, 186:1338-1342.
11. Liu S., Zhang H., Li M., et al. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ. 2013, 20:456-464.
12. Joller N., Lozano E., Burkett P.R., et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 2014, 40:569-581.
13. Kajiwara Y., Schiff T., Voloudakis G., et al. A critical role for human caspase-4 in endotoxin sensitivity. J. Immunol. 2014, 193:335-343.
14. Chellan B., Yan L., Sontag T.J., et al. IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1. J. Lipid Res. 2014, 55:443-454.
15. Cribbs A.P., Kennedy A., Gregory B., et al. Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells. BMC Biotechnol. 2013, 13:98.
16. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
17. Cao S., Liu J., Song L., et al. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J. Immunol. 2005, 174:3484-3492.
18. Li M., Xia P., Du Y., et al. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling. J. Biol. Chem. 2014, 289:17647-17657.
19. Foks A.C., Ran I.A., Frodermann V., et al. Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development. PLoS One 2013, 8:e83134.
20. Cerboni C., Fionda C., Soriani A., et al. The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells. Front Immunol. 2014, 4:508.
21. Levin S.D., Taft D.W., Brandt C.S., et al. Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur. J. Immunol. 2011, 41:902-915.
22. Maier M.K., Seth S., Czeloth N., et al. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Eur. J. Immunol. 2007, 37:2214-2225.
23. Lozano E., Dominguez-Villar M., Kuchroo V., et al. The TIGIT/CD226 axis regulates human T cell function. J. Immunol. 2012, 188:3869-3875.
24. Hodi F.S., O'Day S.J., McDermott D.F., et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 2010, 363:711-723.
25. Merrill J.T. Co-stimulatory molecules as targets for treatment of lupus. Clin. Immunol. 2013, 148:369-375.
26. + T cell effector function. Cancer Cell 2014, 26:923-937.
27. Laoui D., Van O., vermeire E., De B., aetselier P., et al. Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front Immunol. 2014, 5:489.
28. Ko S.Y., Ladanyi A., Lengyel E., et al. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. Am. J. Pathol. 2014, 184:271-281.
29. Cao S., Liu J., Chesi M., et al. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 2002, 169:5715-5725.
30. Schreiber T., Ehlers S., Heitmann L., et al. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 2009, 183:1301-1312.
31. Shimura E., Shibui A., Narushima S., et al. Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock. Biochem. Biophys. Res. Commun. 2014, 453:1-6.
32. Hashimoto D., Miller J., Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011, 35:323-335.
33. Pils M.C., Pisano F., Fasnacht N., et al. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur. J. Immunol. 2010, 40:443-448.
34. Giacomini E., Iona E., Ferroni L., et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 2001, 166:7033-7041.
35. Stout R.D., Jiang C., Matta B., et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 2005, 175:342-349.
36. Nayyar A., Dawicki W., Huang H., et al. Induction of prolonged asthma tolerance by IL-10-differentiated dendritic cells: differential impact on airway hyperresponsiveness and the Th2 immunoinflammatory response. J. Immunol. 2012, 189:72-79.